The 77 references in paper Z. Stark, R. Savarirayan, З. Старк, Р. Саварирайан (2010) “ОСТЕОПЕТРОЗ // OSTEOPETROSIS” / spz:neicon:nefr:y:2010:i:2:p:20-34

1
A lb e rs-S ch on b e rg R ontgenbilder einer seltenen Knockenerkrankung. Munch Med Wochensch. 1904;5:365-368
(check this in PDF content)
2
Superti-Furga A US, and the Nosology Group o f the International Skeletal Dysplasia S ociety N osology and Classification of Genetic Skeletal Disorders: 2006 Revision. American Journal of Medical Genetics Part A. 2007;143A:1-18. doi: 10.1002/ajmg.a.31483
(check this in PDF content)
3
Loria-Cortes R, Quesada-Calvo E, Cordero-Chaverri C. O steopetrosis in children: a report of 26 cases. J Pediatr 1977;91:43-47
(check this in PDF content)
4
Bollerslev J, Andersen PE, Jr Radiological, biochemical and hereditary evidence of two types of autosomal dominant osteopetrosis. Bone 1988;9:7-13
(check this in PDF content)
5
Al-Tamimi YZ, Tyagi AK, Chumas PD, Crimmins DW. Patients with autosom al-recessive osteopetrosis presenting with hydrocephalus and hindbrain posterior fossa crowding. J Neurosurg Pediatrics. 2008;1:103-106
(check this in PDF content)
6
Dozier TS, Duncan IM, Klein AJ, Lambert PR, Key LL., Jr O tologic m anifestations of m alignant o steopetrosis. Otol Neurotol. 2005;26:762-766
(check this in PDF content)
7
Maranda B, Chabot G, Decarie JC, Pata M, Azeddine B, Moreau A, Vacher J. Clinical and cellular manifestations of O STM 1-related infantile osteopetrosis. J Bone Miner Res 2008;23:296-300
(check this in PDF content)
8
Steward CG. Neurological aspects o f osteopetrosis. Neuropathol Appl Neurobiol 2003;29:87-97
(check this in PDF content)
9
Alroy J, Pfannl R, Ucci A, Lefranc G, Frattini A, Megarbane A. Electron microscopic findings in skin biopsies from patients with infantile osteopetrosis and neuronal storage disease. Ultrastruct Pathol 2007;31:333-338
(check this in PDF content)
10
Jacquemin C, Mullaney P, Svedberg E. Marble brain syndrome: osteopetrosis, renal acidosis and calcification of the brain. Neuroradiology 1998;40:662-663
(check this in PDF content)
11
Whyte MP. Carbonic anhydrase II deficiency. Clin Orthop Relat Res. 1993:52-63
(check this in PDF content)
12
Guerrini MM, Sobacchi C, Cassani B, Abinun M, Kilic SS, Pangrazio A, Moratto D, Mazzolari E, Clayton-Smith J, Orchard P, et al. Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations. Am J Hum Genet 2008;83:64-76
(check this in PDF content)
13
Kilic SS, Etzioni A. The Clinical Spectrum of Leukocyte Adhesion Deficiency (LAD) III due to Defective CalDAG-GEF1. J Clin Immunol 2008
(check this in PDF content)
14
Mory A, Feigelson SW, Yarali N, Kilic SS, Bayhan GI, Gershoni-Baruch R, Etzioni A, Alon R. Kindlin-3: a new gene involved in the pathogenesis of LAD-III. Blood 2008;112:2591
(check this in PDF content)
15
Benichou OD, Laredo JD, de Vernejoul MC. Type II autosom al d om inant o ste o p e tro sis (A lbers-S chonberg disease): clinical and radiological manifestations in 42 patients. Bone 2000;26:87-93
(check this in PDF content)
16
Maroteaux P, Lamy M. [Pyknodysostosis.]. Presse Med 1962;70:999-1002
(check this in PDF content)
17
Maroteaux P, Lamy M. The Malady of Toulouse-Lautrec. Jama 1965;191:715-717
(check this in PDF content)
18
Bartsocas CS. Pycnodysostosis: Toulouse-Lautrec’s and Aesop’s disease? Hormones (Athens) 2002;1:260-262
(check this in PDF content)
19
Edelson JG, Obad S, Geiger R, On A, A rtul HJ. Pycnodysostosis. Orthopedic aspects with a description of 14 new cases. Clin Orthop Relat Res 1992:263-276
(check this in PDF content)
20
Muto T, Michiya H, Taira H, Murase H, Kanazawa M. Pycnodysostosis. Report of a case and review of the Japanese literature, with emphasis on oral and maxillofacial findings. Oral Surg Oral Med Oral Pathol 1991;72:449-455
(check this in PDF content)
21
Jones CM, Rennie JS, Blinkhorn AS. Pycnodysostosis. A review of reported dental abnormalities and a report of the dental findings in two cases. Br Dent J 1988;164:218-220
(check this in PDF content)
22
Soliman AT, Ramadan MA, Sherif A, Aziz Bedair ES, Rizk MM. Pycnodysostosis: clinical, radiologic, and endocrine evaluation and linear growth after growth hormone therapy. Metabolism 2001;50:905-911
(check this in PDF content)
23
Baker RK, Wallach S, Tashjian AH, Jr Plasma calcitonin in p ycnodysostosis: in te rm itte n tly high basal levels and exaggerated responses to calcium and glucagon infusions. J Clin Endocrinol Metab 1973;37:46-55
(check this in PDF content)
24
Spranger J, Albrecht C, Rohwedder HJ, Wiedemann HR. [D ysosteosclerosis - a special form o f generalized osteosclerosis]. Fortschr Geb Rontgenstr Nuklearmed 1968; 109:504-512
(check this in PDF content)
25
Elcioglu NH, Vellodi A, Hall CM. Dysosteosclerosis: a report o f three new cases and evolution of the radiological findings. J Med Genet 2002;39:603-607
(check this in PDF content)
26
Ghai S, Sharma R, Ghai S. Mixed sclerosing bone dysplasia - a case report with literature review. Clin Imaging 2003; 27:203-205
(check this in PDF content)
27
Butkus CE, Michels VV, Lindor NM, Cooney WP 3rd Melorheostosis in a patient with familial osteopoikilosis. Am J Med Genet 1997;72:43-46
(check this in PDF content)
28
Debeer P, Pykels E, Lammens J, Devriendt K, Fryns JP M elorheostosis in a fam ily w ith autosom al dom inant osteopoikilosis: report of a third family. Am J Med Genet A 2003;119A
(check this in PDF content)
29
Nevin NC, Thomas PS, Davis RI, Cowie GH. M elorheostosis in a fam ily w ith autosom al dom inant osteopoikilosis. Am J Med Genet 1999; 82:409-414
(check this in PDF content)
30
Voorhoeve N. L’image radiologique non encore decrit d ’une anom alie du squelette; ses ra pports avec la dyschondroplasie et l’osteopathia condensans disseminata. Acta Radiol 1924;3:407-427
(check this in PDF content)
31
Savarirayan R, Nance J, Morris L, Haan E, Couper R. Osteopathia striata with cranial sclerosis: highly variable phenotypic expression within a family. Clin Genet 1997;52:199-205
(check this in PDF content)
32
Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 2000;21:115-137
(check this in PDF content)
33
W alker DG. The classic: O steopetrosis cured by temporary parabiosis. Clin Orthop Relat Res 1982:2-3
(check this in PDF content)
34
Doffinger R, Smahi A, Bessia C, Geissmann F, Feinberg J, Durandy A, Bodemer C, Kenwrick S, Dupuis-Girod S, Blanche S, et al. X -linked a n h id ro tic ectoderm al dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet 2001;27:277-285
(check this in PDF content)
35
Yoshida H, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, Okamura H, Sudo T, Shultz LD, Nishikawa S. The murine m utation o ste o p e tro sis is in the coding region o f the macrophage colony stimulating factor gene. Nature 1990; 345: 442-444
(check this in PDF content)
36
Sobacchi C, Frattini A, Guerrini MM, Abinun M, Pangrazio A, Susani L, Bredius R, Mancini G, Cant A, Bishop N et al. Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL. Nat Genet 2007;39:960-962
(check this in PDF content)
37
Kornak U, Kasper D, Bosl MR, Kaiser E, Schweizer M, Schulz A, Friedrich W, Delling G, Jentsch TJ. Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell 2001;104:205-215
(check this in PDF content)
38
Frattini A, Orchard PJ, Sobacchi C, Giliani S, Abinun M, Mattsson JP, Keeling DJ, Andersson AK, Wallbrandt P, Zecca L, et al. Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat Genet 2000;25:343-346
(check this in PDF content)
39
Kornak U, Schulz A, Friedrich W, Uhlhaas S, Kremens B, Voit T, Hasan C, Bode U, Jentsch TJ, Kubisch C. Mutations in the a3 subunit o f the vacuolar H(+)-ATPase cause infantile malignant osteopetrosis. Hum Mol Genet 2000;9:2059-2063
(check this in PDF content)
40
Li YP, Chen W, Liang Y Li E, Stashenko P. Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast- mediated extracellular acidification. Nat Genet 1999;23:447- 451
(check this in PDF content)
41
Sobacchi C, Frattini A, Orchard P Porras O, Tezcan I, Andolina M, Babul-Hirji R, Baric I, Canham N, Chitayat D, et al. The m utational spectrum o f human m alignant autosom al recessive osteopetrosis. Hum Mol Genet 2001;10:1767-1773
(check this in PDF content)
42
Kasper D, Planells-Cases R, Fuhrmann JC, Scheel O, Zeitz O, Ruether K, Schmitt A, Poet M, Steinfeld R, Schweizer M, et al. Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration. Embo J 2005;24:1079- 1091
(check this in PDF content)
43
Cleiren E, Benichou O, Van Hul E, Gram J, Bollerslev J, Singer FR, Beaverson K, Aledo A, Whyte MP, Yoneyama T, et al. Albers-Schonberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene. Hum Mol Genet 2001;10:2861-2867
(check this in PDF content)
44
Lange PF, Wartosch L, Jentsch TJ, Fuhrmann JC. ClC-7 requires Ostm1 as a beta-subunit to support bone resorption and lysosomal function. Nature 2006;440:220-223
(check this in PDF content)
45
Chalhoub N, Benachenhou N, Vacher J. Physical and transcriptional map of the mouse Chromosome 10 proximal region syntenic to human 6q16-q21. Mamm Genome 2001; 12: 887-892
(check this in PDF content)
46
Ramirez A, Faupel J, Goebel I, Stiller A, Beyer S, Stockle C, Hasan C, Bode U, Kornak U, Kubisch C. Identification of a novel mutation in the coding region o f the grey-lethal gene OSTM1 in human malignant infantile osteopetrosis. Hum Mutat 2004;23:471-476
(check this in PDF content)
47
Sly WS, Hewett-Emmett D, Whyte MP, Yu YS, Tashian RE. Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. Proc Natl Acad Sci USA 1983;80:2752-2756
(check this in PDF content)
48
Everts V, Korper W, Hoeben KA, Jansen ID, Bromme D, Cleutjens KB, Heeneman S, Peters C, Reinheckel T, Saftig P, Beertsen W. Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone. J Bone Miner Res 2006;21:1399-1408
(check this in PDF content)
49
Troen BR. The regulation o f cathepsin K gene expression. Ann N YAcad Sci 2006;1068:165-172
(check this in PDF content)
50
Bossard MJ, Tomaszek TA, Thompson SK, Amegadzie BX Hanning CR, Jones C, Kurdyla JT, McNulty DE, Drake FH, Gowen M, Levy MA. Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification. J Biol Chem 1996;271:12517-12524
(check this in PDF content)
51
Votta BJ, Levy MA, Badger A, Bradbeer J, Dodds RA, James IE, Thompson S, Bossard MJ, Carr T, Connor JR, et al. Peptide aldehyde in h ib ito rs o f cathepsin K in h ib it bone resorption both in vitro and in vivo. J Bone Miner Res 1997; 12: 1396-1406
(check this in PDF content)
52
Saftig P Hunziker E, Wehmeyer O, Jones S, Boyde A, Rommerskirch W, Moritz JD, Schu P, von Figura K. Impaired o s te o c la s tic bone reso rp tio n leads to o ste o p e tro sis in cathepsin-K-deficient mice. Proc Natl Acad Sci USA 1998; 95: 13453-13458
(check this in PDF content)
53
Gowen M, Lazner F, Dodds R, Kapadia R, Feild J, Tavaria M, Bertoncello I, Drake F, Zavarselk S, Tellis I et al. Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization. J Bone Miner Res 1999; 14: 1654-1663
(check this in PDF content)
54
Gelb BD, Shi GP, Chapman HA, D esnick RJ. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 1996;273:1236-1238
(check this in PDF content)
55
Johnson MR, Polymeropoulos MH, Vos HL, Ortiz de Luna RI, Francomano CA. A nonsense mutation in the cathepsin K gene observed in a family with pycnodysostosis. Genome Res 1996;6:1050-1055
(check this in PDF content)
56
Wesenbeeck L, Odgren PR, Coxon FP, Frattini A, Moens P, Perdu B, MacKay CA, Van Hul E, Timmermans JP, Vanhoenacker F, et al. Involvement of PLEKHM1 in osteoclastic vesicular transport and osteopetrosis in incisors absent rats and humans. J Clin Invest 2007;117:919-930
(check this in PDF content)
57
Wesenbeeck L, Odgren PR, Mackay CA, Van Hul W. Localization of the gene causing the osteopetrotic phenotype in the incisors absent (ia) rat on chromosome 10q32.1. J Bone Miner Res 2004;19:183-189
(check this in PDF content)
58
Hellemans J, Preobrazhenska O, Willaert A, Debeer P Verdonk PC, Costa T, Janssens K, Menten B, Van Roy N, Vermeulen SJ, et al. Loss-of-function mutations in LEMD3 result in o ste o p o ikilo sis, B u sch ke -O llen d o rff syndrom e and melorheostosis. Nat Genet 2004;36:1213-1218
(check this in PDF content)
59
Hellemans J, Debeer P Wright M, Janecke A, Kjaer KW, Verdonk PC, Savarirayan R, Basel L, Moss C, Roth J, et al. Germline LEMD3 mutations are rare in sporadic patients with isolated melorheostosis. Hum Mutat 2006;27:290
(check this in PDF content)
60
Grzeschik KH, Bornholdt D, Oeffner F, Konig A, del Carmen Boente M, Enders H, Fritz B, Hertl M, Grasshoff U, Hofling K, et al. D eficiency of PORCN, a regulator o f Wnt signaling, is associated with focal dermal hypoplasia. Nat Genet 2007; 39:833-835
(check this in PDF content)
61
Wang X, Reid Sutton V, Omar Peraza-Llanes J, Yu Z, Rosetta R, Kou YC, Eble TN, Patel A, Thaller C, Fang P Veyver IB Van den. Mutations in X-linked PORCN, a putative regulator of Wnt signaling, cause focal derm al hypoplasia. Nat Genet 2007;39:836-838
(check this in PDF content)
62
Jenkins ZA, van Kogelenberg M, Morgan T, Jeffs A, Fukuzawa R, Pearl E, Thaller C, Hing AV, Porteous ME, Garcia- Minaur S, et al. Germline mutations in WTX cause a sclerosing skeletal dysplasia but do not predispose to tum origenesis. Nat Genet 2009;41:95-100
(check this in PDF content)
63
Waguespack SG, Hui SL, White KE, Buckwalter KA, Econs MJ. Measurement of tartrate-resistant acid phosphatase and the brain isoenzym e o f creatine kinase a ccu ra te ly diagnoses type II autosomal dominant osteopetrosis but does not identify gene carriers. J Clin Endocrinol Metab 2002; 87: 2212-2217
(check this in PDF content)
64
Alatalo SL, Ivaska KK, Waguespack SG, Econs MJ, Vaananen HK, Halleen JM. Osteoclast-derived serum tartrate- resistant acid phosphatase 5b in Albers-Schonberg disease (type II autosomal dominant osteopetrosis). Clin Chem 2004; 50: 883-890
(check this in PDF content)
65
Del Fattore A, Peruzzi B, Rucci N, Recchia I, Cappariello A, Longo M, Fortunati D, Ballanti P Iacobini M, Luciani M, et al. Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment. J Med Genet 2006; 43:315-325
(check this in PDF content)
66
Ogur G, Ogur E, Celasun B, Baser I, Imirzalioglu N, Ozturk T, Alem daroglu A. Prenatal diagnosis of autosomal recessive osteopetrosis, infantile type, by X-ray evaluation. Prenat Diagn 1995;15:477-481
(check this in PDF content)
67
Landa J, M argolis N, Di Cesare P O rthopaedic management o f the patient with osteopetrosis. J Am Acad Orthop Surg 2007;15:654-662
(check this in PDF content)
68
Hwang JM, Kim IO, Wang KC. Complete visual recovery in osteopetrosis by early optic nerve decompression. Pediatr Neurosurg 2000;33:328-332
(check this in PDF content)
69
Driessen GJ, Gerritsen EJ, Fischer A, Fasth A, Hop WC, Veys P, Porta F, Cant A, Steward CG, Vossen JM et al. Long­ term outcome of haematopoietic stem cell transplantation in autosomal recessive osteopetrosis: an EBMT report. Bone Marrow Transplant 2003;32:657-663
(check this in PDF content)
70
Steward CG, Pellier I, Mahajan A, Ashworth MT, Stuart AG, Fasth A, Lang D, Fischer A, Friedrich W, Schulz AS. Severe pulmonary hypertension: a frequent complication of stem cell transplantation fo r m alignant infantile osteopetrosis. Br J Haematol 2004;124:63-71
(check this in PDF content)
71
Frattini A, Blair HC, Sacco MG, Cerisoli F, Faggioli F, Cato EM, Pangrazio A, Musio A, Rucci F, Sobacchi C, et al. Rescue of ATPa3-deficient murine malignant osteopetrosis by hematopoietic stem cell transplantation in utero. Proc Natl Acad SciUSA 2005;102:14629-14634
(check this in PDF content)
72
Key LL, Jr, Ries WL, R odriguiz RM, H atcher HC. R ecom binant human in te rfe ro n gamma th e ra p y for osteopetrosis. J Pediatr 1992;121:119-124
(check this in PDF content)
73
Key LL, Jr, Rodriguiz RM, Willi SM, Wright NM, Hatcher HC, Eyre DR, Cure JK, Griffin PP, Ries WL. Long-term treatment of osteopetrosis with recombinant human interferon gamma. N Engl J Med 1995;332:1594-1599
(check this in PDF content)
74
Kocher MS, Kasser JR. Osteopetrosis. Am J Orthop 2003; 32:222-228
(check this in PDF content)
75
Key L, Carnes D, Cole S, Holtrop M, Bar-Shavit Z, Shapiro F, Arceci R, Steinberg J, Gundberg C, Kahn A et al. Treatment of congenital osteopetrosis with high-dose calcitriol. N Engl J Med 1984;310:409-415
(check this in PDF content)
76
Villa A, Guerrini MM, Cassani B, Pangrazio A, Sobacchi C. Infantile Malignant, Autosomal Recessive Osteopetrosis: The Rich and The Poor. Calcif Tissue Int 2008
(check this in PDF content)
77
Del Fattore ACA, Teti A. Genetics, pathogenesis and complications of osteopetrosis. Bone 2008;42:19-29 Перевод с английского Я.Ю. Проплетов Поступила в редакцию 14.01.2010 г. Принята в печать 02.06.2010 г.
(check this in PDF content)